Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Landscape Professional Research Report 2024

Research Summary

Pharmacogenomics technology, also known as therapeutic diagnosis or companion diagnosis (CDx), involves the use of genetic information to personalize medical treatments, particularly in the field of drug prescription. It focuses on understanding how an individual's genetic makeup influences their response to medications. By analyzing genetic variations, such as single nucleotide polymorphisms (SNPs), pharmacogenomics aims to identify patients who are more likely to respond positively to a specific treatment, those who may experience adverse reactions, and individuals who may not respond effectively to certain drugs. Companion diagnostics play a crucial role in tailoring treatment plans, allowing healthcare providers to make more informed decisions about drug selection, dosage, and potential side effects based on a patient's genetic profile. This approach enhances the efficacy and safety of medical treatments, providing a more personalized and targeted approach to healthcare.

According to DIResearch's in-depth investigation and research, the global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) include Qiagen, GE Healthcare, Agilent Technologies, F Hoffman La Roche, Foundation Medicine, Thermo Fisher Scientific, Leica Biosystems Nussloch, Pfizer etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx). Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Include:

Qiagen

GE Healthcare

Agilent Technologies

F Hoffman La Roche

Foundation Medicine

Thermo Fisher Scientific

Leica Biosystems Nussloch

Pfizer

Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Segment Include:

PCR

In-situ Hybridization

Immunohistochemistry

Sequencing

Others

Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Application Include:

Oncology

Neurological Disorders

Cardiovascular Disease

Immunological Disorders

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry PESTEL Analysis

Chapter 3: Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry Porter's Five Forces Analysis

Chapter 4: Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Major Regional Market Size and Forecast Analysis

Chapter 5: Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Overview

1.1 Product Definition and Statistical Scope

1.2 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product by Type

1.2.1 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 PCR

1.2.3 In-situ Hybridization

1.2.4 Immunohistochemistry

1.2.5 Sequencing

1.2.6 Others

1.3 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product by Application

1.3.1 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Oncology

1.3.3 Neurological Disorders

1.3.4 Cardiovascular Disease

1.3.5 Immunological Disorders

1.3.6 Others

1.4 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Revenue Analysis (2019-2030)

1.5 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Development Status and Trends

1.5.1 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry Development Status Analysis

1.5.2 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry Development Trends Analysis

2 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Analysis by Regions

4.1 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Overall Market: 2023 VS 2024 VS 2030

4.2 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Revenue and Market Share by Region (2019-2024)

4.2.2 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Revenue Forecast by Region (2025-2030)

5 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type and Application

5.1 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

5.2 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

6 North America

6.1 North America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

6.4 North America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

6.5 North America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

7.4 Europe Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

7.5 Europe Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

8.4 China Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

9.4 APAC (excl. China) Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

9.5 APAC (excl. China) Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

10.4 Latin America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

10.5 Latin America Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Type

11.4 Middle East & Africa Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Application

11.5 Middle East & Africa Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Revenue by Key Manufacturers (2020-2024)

12.2 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Landscape Analysis and Market Dynamic

12.2.1 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Qiagen

13.1.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Qiagen Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.1.3 Qiagen Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 GE Healthcare

13.2.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 GE Healthcare Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.2.3 GE Healthcare Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Agilent Technologies

13.3.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Agilent Technologies Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.3.3 Agilent Technologies Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 F Hoffman La Roche

13.4.1 F Hoffman La Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 F Hoffman La Roche Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.4.3 F Hoffman La Roche Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Foundation Medicine

13.5.1 Foundation Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Foundation Medicine Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.5.3 Foundation Medicine Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Thermo Fisher Scientific

13.6.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Thermo Fisher Scientific Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.6.3 Thermo Fisher Scientific Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Leica Biosystems Nussloch

13.7.1 Leica Biosystems Nussloch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Leica Biosystems Nussloch Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.7.3 Leica Biosystems Nussloch Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Pfizer

13.8.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Pfizer Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Product Portfolio

13.8.3 Pfizer Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry Chain Analysis

14.2 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Typical Downstream Customers

14.4 Pharmacogenomics Technology/Therapeutic Diagnosis/Companion Diagnosis (CDx) Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support